Biotech

In a significant boost for cancer therapy innovation, AvenCell Therapeutics, Inc. has announced the successful closure of a $112 million Series B funding round. The financing, spearheaded by Novo Holdings, attracted new investors including F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, and NYBC Ventures, alongside existing backer Blackstone Life Sciences. This funding…

In a significant boost for sustainable innovation, Belgian biotech startup AmphiStar has been awarded a €2 million grant from SPRIN-D, Germany’s Federal Agency for Disruptive Innovation. This funding marks a remarkable milestone for the company, bringing its total financing for 2023 to €10 million. The grant is aimed at advancing AmphiStar’s groundbreaking biotechnology platform, which…

In a significant boost for biotechnology innovation, Nuclera has successfully closed a $75 million financing round, aimed at advancing its groundbreaking eProtein Discovery platform. This Series C round was led by Elevage Medical Technologies and saw participation from various prominent investors, including Patient Square Capital, British Patient Capital, Cambridge Innovation Capital, and others. This substantial…

Antiverse, a forward-thinking techbio company focused on antibody design for challenging therapeutic targets, has successfully raised an additional £3.5M ($4.6M) in its latest funding round. This investment elevates the total funding to £7.2M ($10.1M) and will significantly bolster Antiverse’s growth initiatives, including the expansion of its research facilities in Boston and Prague. The funding was…

Nomic Bio, a leader in protein profiling, has successfully completed a $42 million Series B funding round that was oversubscribed. This significant capital infusion will propel the company’s efforts to enhance its cutting-edge protein profiling platform and expand its commercial operations, catering to the rising demand in the proteomics field. Led by a prominent U.S.-based…

Arzeda, the Protein Design Company™, has successfully closed a $38 million oversubscribed funding round aimed at advancing its groundbreaking protein design technologies. This funding round attracted significant investments from Sofinnova Partners, Fall Line Capital, Sucden Ventures, Silver Blue, and the venture arm of W.L. Gore & Associates, known for their Gore-Tex® innovations. Previous supporters such…